Clinical Trial Update: A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety [Phase 2]

View source ↗

Summary

Phase 2 study in rheumatoid arthritis comparing two formulations of adalimumab to evaluate pharmacokinetics, pharmacodynamics, and safety. The trial is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2014-06-11